Products on this website are for legitimate laboratory research use only and are
not for human consumption. By continuing, you confirm you are 21 years or older.
If you are under 21 years, please leave this site.
Is Retatrutide a Steroid? Peptide Classification & Research Context
January 26, 2026•PEPTIDES SKIN RESEARCH DESK
RESEARCH USE ONLY. NOT FOR HUMAN OR VETERINARY USE, DIAGNOSIS, TREATMENT, OR PREVENTION.
Classification
Retatrutide (LY3437943) is an investigational synthetic peptide studied as an agonist of the GIP, GLP-1, and glucagon receptors. It is not an anabolic steroid. This molecular classification does not establish safety, effectiveness, or suitability for any use.
FDA has included retatrutide among unapproved GLP-1 drugs in its consumer alert. A “research use only” label does not make an unapproved drug appropriate for human use. See FDA’s alert.
Regulatory Context and Research Scope
21 CFR Part 809 concerns labeling for in vitro diagnostic products. Section 809.10(c) is not a general legal basis for a peptide’s research-use-only status. See FDA’s overview of in vitro diagnostic labeling requirements.
This article does not provide dosing, administration, preparation, or storage instructions. Products designated for research are not intended for use in people or animals.
Frequently Asked Questions
Is retatrutide a steroid?
No. Retatrutide is a peptide-based investigational molecule, not a steroid structure.
Does research classification mean approval?
No. A research classification does not establish FDA approval, safety, or suitability for people.
Does Peptides Skin provide human-use instructions?
No. The catalog and articles are limited to research-use-only contexts.
science
REFERENCE COMPOUNDS & COA DIRECTORY
DISPATCH IN 24–48H
Browse research-use-only compounds. Batch-specific documentation may be requested after purchase for manual verification:
